SAN DIEGO, Calif., Feb. 27 /PRNewswire/ -- You are invited to listen to world-renowned allergist Eli Meltzer, M.D. discuss new data on fluticasone furoate nasal spray that was recently presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI).
What: Dr. Eli Meltzer Discusses New Data on Fluticasone Furoate Nasal Spray When: Podcast available for download on February 27, 2007 Where: http://feeds.feedburner.com/allergymanagement How: Log into the URL above and follow the subscription instructions on the website Contact: Janene Ferrara of Marina Maher Communications, 212-485-6843 Dr. Meltzer is available for interviews
Dr. Meltzer is co-director of Allergy & Asthma Medical Group and Research Center, as well as Clinical Professor of Pediatrics at the University of California, both in San Diego. He has participated in nearly 600 research studies focused on various aspects of respiratory disease and authored more than 400 scientific publications.
Fluticasone furoate nasal spray is an enhanced affinity intranasal corticosteroid (INS) currently in development by GlaxoSmithKline (GSK) for use in the treatment of allergic rhinitis. The new agent is currently under review by the U.S. Food and Drug Administration to treat the symptoms of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR).
Minimum Requirements: a computer, a broadband Internet connection, a portable MP3 player or MP3-player application on your computer, podcasting software and QuickTime 7. If you experience problems downloading the podcast, send an email to webcast@multivu.com.
Audio: http://feeds.feedburner.com/allergymanagementGlaxoSmithKlineCONTACT: Janene Ferrara of Marina Maher Communications, +1-212-485-6843
